MYRIAD GENETICS, INC. Amendment to Executive Retention AgreementExecutive Retention Agreement • February 5th, 2008 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
Contract Type FiledFebruary 5th, 2008 Company Industry JurisdictionTHIS AMENDMENT TO EXECUTIVE RETENTION AGREEMENT (the “Amendment”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and _______________ (the “Executive”), is entered into effective as of October 12, 2007 (the “Effective Date”).